0000000000957533

AUTHOR

Paola Pizzillo

showing 21 related works from this author

Infezione occulta da HBV in pazienti con malattie oncoematologiche

2005

researchProduct

EVALUATING THE RISK OF HEPATITIS B REACTIVATION IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: IS THE SERUM HEPATITIS B PROFILE RELIABLE?

2009

Background/Aim: Patients with an occult hepatitis B virus (HBV) infection undergoing deep immunosuppression are potentially at risk of HBV reactivation. In order to assess whether a polymerase chain reaction (PCR) assay for HBV DNA in serum could be used to predict the reactivation of an occult HBV infection, we performed a retrospective study in a cohort of Sicilian patients with oncohaematological diseases. Methods: We studied by a highly sensitive ad hoc nested PCR for serum HBV DNA 75 HBsAg-negative oncohaematological patients requiring chemotherapy. Results: Thirty-three patients (44%) were HBV seronegative (anti-HBc and anti-HBs negative) and 42 patients (56%) were HBV seropositive (a…

nested PCRSettore MED/07 - Microbiologia E Microbiologia ClinicaSettore MED/12 - GastroenterologiaIMMUNOSUPPRESSIONSettore MED/09 - Medicina InternaHBsAg SEROREVERSIONOBI
researchProduct

ATTIVITA’ IN VITRO DI ANIDULAFUNGINA, CASPOFUNGINA, VORICONAZOLO, ITRACONAZOLO E FLUCONAZOLO NEI CONFRONTI DI ISOLATI CLINICI DI CANDIDA SPP.

2007

researchProduct

RIATTIVAZIONE DELL’INFEZIONE OCCULTA DA HBV NEL PAZIENTE IMMUNOCOMPROMESSO: STUDIO DELLA ETEROGENEITÀ VIRALE

2006

researchProduct

RUOLO DELL’INFEZIONE OCCULTA DA HBV NEL PAZIENTE IMMUNOCOMPROMESSO

2005

-

lcsh:QR1-502lcsh:MicrobiologyMicrobiologia Medica
researchProduct

Evaluating the risk of hepatitis B reactivation in patients with haematological malignancies: is the serum hepatitis B virus profile reliable?

2009

Background/Aim: Patients with an occult hepatitis B virus (HBV) infection undergoing deep immunosuppression are potentially at risk of HBV reactivation. In order to assess whether a polymerase chain reaction (PCR) assay for HBV DNA in serum could be used to predict the reactivation of an occult HBV infection, we performed a retrospective study in a cohort of Sicilian patients with oncohaematological diseases. Methods: We studied by a highly sensitive ad hoc nested PCR for serum HBV DNA 75 HBsAg-negative oncohaematological patients requiring chemotherapy. Results: Thirty-three patients (44%) were HBV seronegative (anti-HBc and anti-HBs negative) and 42 patients (56%) were HBV seropositive (a…

MaleHBsAgHepatitis B virusHepatitis C virusAntineoplastic AgentsComorbiditymedicine.disease_causePolymerase Chain ReactionSerologyCohort StudiesBlood serumHepatitis B ChronicPredictive Value of TestsRecurrenceRisk FactorsmedicineHumansSeroconversionRetrospective StudiesHepatitis B virusHepatologybusiness.industryvirus diseasesHepatitis BMiddle Agedmedicine.diseasedigestive system diseasesItalyHematologic NeoplasmsImmunologyDNA ViralFemaleVirus ActivationbusinessNested polymerase chain reactionLiver international : official journal of the International Association for the Study of the Liver
researchProduct

Phylogenetic Analysis of isolates from new cases of HBV infection in Southern Italy.

2012

The level of endemicity of hepatitis B virus (HBV) infections in Italy is low and genotype D infections predominant. New HBV strains may however be introduced as a result of movements of people from regions of high endemicity. The aim of the present study was to determine whether strains from new cases of acute hepatitis B detected in southern Italy were due to endemic or new HBV strains. We studied 34 isolates from patients with acute hepatitis B infection, and 35 from chronic hepatitis B patients. A phylogenetic analysis of preS/S region was done by comparing the sequences from the acute and chronic cases with references sequences. The study showed that 44% of strain from acute hepatitis …

Microbiology (medical)AdultMalemedicine.medical_specialtyHepatitis B virusSettore MED/07 - Microbiologia E Microbiologia ClinicaGenotypeBiologymedicine.disease_causeMicrobiologyLiver diseaseEpidemiologyGenotypeGeneticsmedicineHumansMolecular BiologyEcology Evolution Behavior and SystematicsPhylogenyAgedHepatitis B virusAged 80 and overMolecular EpidemiologySettore MED/12 - GastroenterologiaMolecular epidemiologyPhylogenetic treeSequence Analysis DNAHepatitis BMiddle Agedmedicine.diseaseHepatitis BVirologyInfectious DiseasesItalyImmunologyDNA ViralFemaleViral hepatitisHBV genotypes molecular epidemiology Acute HBV infection phylogenetic analysis
researchProduct

Phylogenetic reconstruction of HCV genotype 1b dissemination in a small city centre: The Camporeale model

2008

Several seroepidemiological population-based surveys carried out in Italy have shown a high prevalence of hepatitis C virus (HCV) infection. Camporeale (CP), a small Sicilian town with a 10.4% prevalence of HCV mostly genotype 1b, probably represents a specific context, since intravenous drug addiction, and sexual promiscuity are almost absent. In order to reconstruct the pattern of introduction and diffusion of HCV in this ecological niche, the NS5 genomic region of 72 HCV genotype 1 isolates (39 from CP and 33 collected throughout Sicily) was amplified and sequenced. Sequences were aligned and analyzed by BioEdit, PAUP and BEAST, and their molecular evolution compared. Thirty-eight HCV ge…

MaleSettore MED/07 - Microbiologia E Microbiologia ClinicaUrban PopulationSequence analysisIatrogenic DiseasePopulationHepacivirusViral Nonstructural Proteinsmolecular epidemiologyMonophylyFlaviviridaecoalescent inference analysiPhylogeneticsVirologyGenotypePrevalenceCluster AnalysisHumanshepatitis C virueducationSicilyPhylogenyAgedGeneticsSettore MED/12 - Gastroenterologiaeducation.field_of_studyMolecular epidemiologybiologyPhylogenetic treeSequence Analysis RNAiatrogenic routeBayes TheoremHepatitis C ChronicMiddle Agedbiology.organism_classificationHepatitis CVirologyInfectious DiseasescommunityFemaleMonte Carlo MethodJournal of Medical Virology
researchProduct

HCV genotypes in Sicily: is there any evidence of a shift?

2009

The distribution of HCV strains in any area is characterized by a relative prevalence of one genotype, and a number of less prevalent types. In some Western countries a change from the prevalent HCV genotype 1 to genotypes 3 and 4 has been reported in the last decade. In order to assess possible variations of the distribution of HCV genotypes in Sicily, a southern region of Italy, a hospital-based cohort, collected prospectively, of 3,209 subjects with chronic HCV infection was surveyed, comparing the distribution of HCV genotypes during two consecutive periods, from 1997 to 2002 and from 2003 to 2007, according to age and gender. The results show that genotype 1b, which has been historical…

AdultMaleSettore MED/07 - Microbiologia E Microbiologia ClinicaAdolescentGenotypeHepatitis C virusHepacivirusmedicine.disease_causeCohort StudiesFlaviviridaeYoung AdultVirologyGenotypemedicinePrevalenceHumansProspective StudiesChildGenotypingSicilyAgedAged 80 and overSettore MED/12 - GastroenterologiaMolecular EpidemiologyMolecular epidemiologybiologybusiness.industryInfantHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseasebiology.organism_classificationVirologyhepatitis C virusmolecular epidemiology genotypingHCV prevalencechronic hepatitisInfectious DiseasesCohort effectChild PreschoolCohortFemalebusinessJournal of medical virology
researchProduct

HCV CLEARANCE AFTER PEG IFN PLUS RBV IMPROVES THE COURSE OF HCV CIRRHOSIS REGARDLESS OF PORTAL HYPERTENSION

2009

medicine.medical_specialtySettore MED/07 - Microbiologia E Microbiologia ClinicaSettore MED/12 - GastroenterologiaCirrhosisHepatologybusiness.industryPEG IFN/RBV HCV CIRRHOSISGastroenterologyHcv clearancemedicine.diseaseGastroenterologyInternal medicinemedicinePortal hypertensionbusiness
researchProduct

150 LIVER RELATED EVENTS AND SURVIVAL IN PATIENTS WITH COMPENSATED HCV CIRRHOSIS: THE ROLE OF SUSTAINED VIROLOGICAL RESPONSE TO PEG-IFN BASED THERAPY…

2011

Virological responsemedicine.medical_specialtyCirrhosisHepatologybusiness.industryInternal medicinemedicinePortal hypertensionIn patientmedicine.diseasebusinessGastroenterologyJournal of Hepatology
researchProduct

VALUTAZIONE DELLA CLEARANCE DI HCV-RNA SOTTO TRATTAMENTO ANTIVIRALE CON TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA)

2005

-

lcsh:QR1-502General Medicinelcsh:MicrobiologyMicrobiologia Medica
researchProduct

Cinetica della risposta virologica e della comparsa di mutanti virali in pazienti con malattia cronica di fegato HBV-correlatain terapia con adefovir

2005

researchProduct

PEG-INTERFERON PLUS RIBAVIRIN IN COMPENSATED HCV CIRRHOSIS WITH PORTAL HYPERTENSION: THE ROLE OF RAPID AND EARLY VIROLOGICAL RESPONSE IN PREDICTING T…

2009

Settore MED/12 - GastroenterologiaSettore MED/07 - Microbiologia E Microbiologia ClinicaPEG IFN/RBV HCV Cirrhosis SVR EVRHCV PEG-Interferon plus Ribavirin Rapid virological response
researchProduct

Occult Hbv infection and its reactivation in immunosuppressed patients.

2011

Settore MED/07 - Microbiologia E Microbiologia ClinicaOccult hbv infectionimmunosuppressed patients.
researchProduct

HCV genotypes in western Sicily: any evidence for a shift?

2008

Background: The relative prevalence of each HCV strain in a specific country is characterized by a predominant genotype and a number of other sub-prevalent types. Over the last decade a shift away from the prevalent HCV G1 towards G3 and G4 has been reported in some countries, and might affect the global management of HCV disease. Aim: In order to assess any possible variation in the prevalence of HCV genotypes in Sicily, we surveyed an hospital based cohort of subjects with chronic HCV infection observed over the last ten years. Patient and methods: 3209 Italian patients resident in Western Sicily, 1842/1367 M/F, between 1 and 89 years of age, presented at our tertiary referral Laboratory …

Settore MED/12 - GastroenterologiaSettore MED/07 - Microbiologia E Microbiologia Clinicahepatitis C virus molecular epidemiology genotyping HCV prevalencechronic hepatitis
researchProduct

PEG_interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting t…

2009

HCV Therapy Rapid virological response
researchProduct

Infezione occulta da HBV in pazienti con malattie linfoproliferative in trattamento chemioterapico

2004

researchProduct

INFEZIONE OCCULTA DA HBV NEL PAZIENTE IMMUNOCOMPROMESSO: STUDIO DELLA ETEROGENEITA’ VIRALE

2007

researchProduct

Riattivazione dell'infezione occulta da HBV nel paziente immunocompromesso:studio dell'eterogeneità virale

2006

researchProduct

Infezione occulta da HBV nel paziente immunocompromesso.studio dell'eterogeneità virale

2007

researchProduct